ホーム › 乳がん › ウィスコンシン › Milwaukee
Milwaukee、WIにおける乳がんの臨床試験
Milwaukeeとその周辺地域（約30マイル以内）の拠点で、乳がんに関する23件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Vanguard Study: Testing a New Way to Screen for Cancer
被験者募集中健康なボランティア歓迎
- Zablocki Veterans Administration Medical Center, Milwaukee
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 他9件
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
被験者募集中第1相
- Research Site, Milwaukee
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
被験者募集中第3相
- Clinical Trial Site, Milwaukee
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
被験者募集中第3相
- Medical College of Wisconsin, Milwaukee
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
被験者募集中第1/2相
- Froedtert & MCW Cancer Center, Milwaukee
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
被験者募集中第3相
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
被験者募集中第2相
- Medical College of Wisconsin, Milwaukee
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
被験者募集中第3相
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- 他8件
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
被験者募集中第1相
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
被験者募集中
- Froedtert Hospital, Milwaukee
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
被験者募集中
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
E-Mindfulness Approaches for Living After Breast Cancer
被験者募集中第3相
- UW Cancer Center at ProHealth Care, Waukesha · 17マイル先
- ProHealth D N Greenwald Center, Mukwonago · 25マイル先
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
被験者募集中第3相
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- 他9件
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Aurora Cancer Care-Milwaukee, Milwaukee
- Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- 他10件
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
被験者募集中観察研究
- Medical College of Wisconsin, Milwaukee
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
被験者募集中第1相
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
被験者募集中観察研究
- Aurora Cancer Care - Wauwatosa, Wauwatosa · 5マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Milwaukee
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
被験者募集中第2相
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Individuals on Hormone Therapy Breast Cancer Screening Pilot
被験者募集中観察研究健康なボランティア歓迎
- Medical College of Wisconsin, Milwaukee
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
被験者募集中観察研究
- Columbia St. Mary's, Milwaukee
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
被験者募集中
- Medical College of Wisconsin, Milwaukee
他の都市における乳がんの試験
- New York City, NY136件の研究
- Houston, TX126件の研究
- Boston, MA112件の研究
- Nashville, TN81件の研究
- Los Angeles, CA73件の研究
- Edison, NJ68件の研究
- St. Louis, MO64件の研究
- Queens, NY64件の研究
- Durham, NC64件の研究
- Chicago, IL59件の研究
- Philadelphia, PA56件の研究
- Dallas, TX55件の研究
Milwaukeeにおける他の研究
- がん（全種類）22件の研究
- 非小細胞肺癌22件の研究
- 多発性骨髄腫21件の研究
- 肺がん21件の研究
- 前立腺がん20件の研究
- 濾胞性リンパ腫19件の研究
- 非ホジキンリンパ腫18件の研究
- 膵臓がん18件の研究
- 急性骨髄性白血病17件の研究
- 卵巣がん17件の研究
- びまん性大細胞型B細胞リンパ腫16件の研究
- バーキットリンパ腫16件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。